RYAH Group, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference
TORONTO, ON / ACCESSWIRE / August 16, 2021 / RYAH Group, Inc. (CSE:RYAH) (the “Company”) is pleased to announce that it has been invited to present at the Emerging Growth Conference on August 18, 2021.
The live, interactive online event will give existing shareholders and the investment community the opportunity to interact with RYAH Chief Executive Officer Gregory Wagner in real time.
Mr. Wagner will perform a presentation and may subsequently open the floor for questions. Please ask your questions during the event, and Mr. Wagner will do his best to get through as many of them as possible.
RYAH Group, Inc. will be presenting at 9:45AM Eastern time for 30 minutes.
Please register here to ensure you are able to attend the conference and receive any updates that are released.
If attendees are not able to join the event live on the day of the conference, an archived webcast will be made available on EmergingGrowth.com, and RYAH will also release a link to the webcast after the event.
About the Emerging Growth Conference
The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services, and other major announcements to the investment community from the convenience of their office, in a time efficient manner.
The conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products and services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as investment advisors and analysts.
All sessions will be conducted through video webcasts and will take place in the Eastern time zone.
About RYAH Group, Inc.
RYAH Group, Inc. (“RYAH”) is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries, pharmaceutical companies, and licensed processors (LPs) to monitor and manage formulation effects on patients and demographics. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle.
This press release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively ‘forward-looking statements‘). All statements contained in this press release that are not statements of historical fact should be considered forward-looking statements. Forward looking statements are often identified by terms such as ‘may,’ ‘should,’ ‘anticipate,’ ‘expect,’ ‘potential,’ ‘believe,’ ‘intend’ or the negative of these terms and similar expressions. Forward-looking statements reflect the Company’s current views and intentions with respect to future events based on current information available to the Company and are necessarily subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with or inherent in the general business and economic conditions in the regions in which the Company operates, and such other factors set out in the Company’s public disclosure documents available under the Company’s profile on SEDAR at www.sedar.com. Readers are further cautioned that the assumptions used in the preparation of such forward-looking statements (including, but not limited to, the assumption that the Conference will be held as anticipated by the Company) may prove to be imprecise and result in actual results differing materially from those anticipated, and, as such, undue reliance should not be placed on forward-looking statements. Should any such risk factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Accordingly, readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur.
The forward-looking statements included in this press release are made as of the date of this press release, and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws. All forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
RYAH GROUP INC CONTACTS
+1 917 210 0543
Chief Executive Officer
+ 1 917 210 0543
KCSA Strategic Communications
+1 646 379 7971
SOURCE: RYAH Medtech Inc